Celularity Inc. (CELU)
NASDAQ: CELU · Real-Time Price · USD
1.730
+0.010 (0.59%)
Nov 5, 2025, 12:27 PM EST - Market open
Celularity Market Cap
Celularity has a market cap or net worth of $46.18 million as of November 5, 2025. Its market cap has decreased by -16.31% in one year.
Market Cap
46.18M
Enterprise Value
115.20M
1-Year Change
-16.31%
Ranking
Category
Stock Price
$1.73
Market Cap Chart
Since August 8, 2019, Celularity's market cap has decreased from $352.19M to $46.18M, a decrease of -86.89%. That is a compound annual growth rate of -27.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 4, 2025 | 45.91M | -1.83% |
| Dec 31, 2024 | 46.77M | -1.00% |
| Dec 29, 2023 | 47.24M | -74.75% |
| Dec 30, 2022 | 187.07M | -70.41% |
| Dec 31, 2021 | 632.14M | 59.91% |
| Dec 31, 2020 | 395.31M | 10.55% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Aug 8, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 772.59B |
| Johnson & Johnson | 455.04B |
| AbbVie | 385.18B |
| UnitedHealth Group | 309.40B |
| AstraZeneca | 253.98B |
| Novartis AG | 237.13B |
| Novo Nordisk | 216.87B |
| Abbott Laboratories | 214.96B |